ROSSELL-TECHSYS
Rossell Techsys has been awarded a contract with Lockheed Martin to build Electrical Wire Harness and Interconnect System (EWIS) parts in support of Lockheed Martin’s MH-60R aircraft that are being supplied to the Indian Navy. Last year, India signed a USD $2.1 billion deal with the United States Government as part of its Foreign Military Sales program for the purchase of 24 Lockheed Martin anti-submarine MH-60R helicopters. The first three of these MH-60R all-weather helicopters, which can support multiple missions with state-of-the-art avionics and sensors, have been delivered to the Indian Navy and are currently undergoing pilot and crew training in the United States. The delivery of 24 helicopters will be completed in five years from the time the deal was concluded. The helicopters will be modified with a variety of "India-unique" equipment and weapons. The induction of these fourth-generation MH-60Rs is expected to further enhance the Indian Navy's three-dimensional capabilities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211110006132/en/
“We are honoured to have been selected to manufacture wire harnesses for the MH-60R, an important equipment for India. We are committed to producing high-quality parts, on time, from India, furthering India’s growing strength in manufacturing to global standards and contributing to Aatmanirbhar Bharat ,” said Mr. Prabhat Kumar Bhagvandas, Chief Executive Officer, Rossell Techsys.
As part of the contract received from Lockheed Martin, Rossell Techsys shall perform “Build to Print” (BTP) manufacture of the wire harnesses that will be installed on the MH-60R. Manufacture of these parts is being performed in the “Center of Excellence” (COE), set up by Rossell Techsys for Lockheed Martin platforms. The manufacture of parts has commenced, with the first parts having successfully undergone acceptance by Lockheed Martin. The contract shall also enable Lockheed Martin to obtain offset credits towards this platform sale.
“We are excited about the opportunity to partner with Rossell Techsys and confident of their vital capability to deliver high quality cable and harness assemblies in support of the India MRH Program and the Indian Navy,” said Hamid Salim, Vice President and General Manager, Sikorsky Maritime and Mission Systems.
About Lockheed Martin
Headquartered in Bethesda, Maryland, Lockheed Martin Corporation is a global security and aerospace company that employs approximately 114,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.
Present in India for over three decades, Lockheed Martin is proud of its longstanding relationships and commitment to customers and partners on existing and future programs ranging from transport, maritime and fighter aircraft, to sea and land-based air and missile defence projects, as well as capabilities in civil sectors including new and renewable energy. A strategic partner and developer of sovereign industrial, workforce and enterprise capability, Lockheed Martin India’s joint ventures, apprenticeships, and founding membership of the India Innovation Growth Program underscore its conviction in Indian industry, talent and progress.
Please follow @LMNews on Twitter for the latest announcements and news across the company.
About Rossell Techsys
Rossell Techsys is the Aerospace & Defense Division of Rossell India Limited, a public listed company. It is an MSME, certified to AS9100, ISO 9001, ISO 14001, ISO 45001, ISO 27001, ISO 37001 and is also ISO 31000 and NIST 800-171 compliant. It operates from a state-of-the-art 225,000 sq. ft., LEED Gold rated facility at Bangalore, providing custom engineering and manufacturing services. Core competencies are in Electrical Wiring and Interconnect Systems (EWIS), Electronic System and Systems Integration (ESSI), Test Equipment and After Market Product Support Services.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110006132/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ant Group Unveils China’s First Multimodal AI Assistant with Code-Driven Outputs18.11.2025 09:05:00 CET | Press release
Ant Group today launched LingGuang, a next-generation multimodal AI assistant and the first of its kind in China that interacts with users through code-driven outputs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117438567/en/ Equipped with the capability to understand and produce language, image, voice and data, LingGuang delivers precise, structured responses to complex queries through 3D models, audio clips, charts, animations, interactive maps, and even immediately generated applications, in addition to traditional text-based conversation. Designed around three key features, LingGuang aims to make complex knowledge simpler and more intuitive, transforming how users access information and interact with AI tools. Fast Research: LingGuang responds to user questions or keywords with dynamic, multimodal content, making research on any topic clearer and more engaging. Its 3D digital modeling capability transcends traditio
SkySparc Appoints Oliver Bussmann as Chairman of the Board18.11.2025 09:00:00 CET | Press release
Appointment of industry veteran follows majority growth investment from Bregal Milestone SkySparc, a trusted global provider of digital transformation solutions for treasury and finance organizations, today announced the appointment of Oliver Bussmann as Chairman of the Board, following the closing of a majority growth investment from Bregal Milestone, a leading European software private equity firm. As former Global CIO at UBS and SAP, Bussmann has a proven track record of scaling B2B software and services across the Office of the CFO, Financial Services, RegTech, and WealthTech. Throughout his career, he has guided organizations through complex SaaS transitions, strategic M&A, and go-to-market acceleration – delivering multiple successful exits and sustained enterprise growth. Bussmann will help steer SkySparc’s technology and value-creation agenda, as Chairman, leveraging his network across financial services and technology to accelerate innovation, expand AI adoption, and drive lon
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab18.11.2025 08:23:00 CET | Press release
Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20%1,3Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency3 Celltrion, Inc. today announced that the European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg vials, the formulation is designed to streamline inf
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 08:00:00 CET | Press release
After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new IDEAL Japan initiativeThe “Innovation Debiopharm Academia Life Science” (IDEAL) program is designed to financially and scientifically support academic research with the goal of accelerating the translation of innovation into novel therapies for patientsThe first IDEAL Japan agreement was signed with the National Cancer Center Japan Research Institute Laboratory of Genome Stability Maintenance to advance research in early-stage colon cancer Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approa
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom